Screener
Recursion Pharmaceuticals, Inc. RXRX Finite-Lived Intangible Assets, Accumulated Amortization
Finite-Lived Intangible Assets, Accumulated Amortization at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
| (in thousands) | June 30, 2026 / Gross carrying amount | June 30, 2026 / Accumulated Amortization | June 30, 2026 / Net carrying amount | December 31, 2025 / Gross carrying amount | December 31, 2025 / Accumulated Amortization | December 31, 2025 / Net carrying amount |
|---|---|---|---|---|---|---|
| Definite-lived technology intangible assets | $233,403 | $(90,223) | $143,180 | $236,497 | $(69,156) | $167,341 |
| Definite-lived licensed intangible assets | 13,073 | (9,137) | 3,936 | 11,158 | (6,619) | 4,539 |
| Indefinite-lived intangible assets | 135,772 | — | 135,772 | 138,023 | — | 138,023 |
| Total intangible assets | $382,248 | $(99,360) | $282,888 | $385,678 | $(75,775) | $309,903 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Recursion Pharmaceuticals, Inc.'s finite-lived intangible assets, accumulated amortization?
- Recursion Pharmaceuticals, Inc. (RXRX) reported finite-lived intangible assets, accumulated amortization of $99.36M in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s finite-lived intangible assets, accumulated amortization changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s finite-lived intangible assets, accumulated amortization increased by 94.2% year-over-year, from $51.16M to $99.36M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s finite-lived intangible assets, accumulated amortization?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s finite-lived intangible assets, accumulated amortization has grown at a 259.0% compound annual growth rate (CAGR), from $127K to $75.78M.
- What does finite-lived intangible assets, accumulated amortization mean?
- Finite-Lived Intangible Assets, Accumulated Amortization
Ask your AI about Recursion Pharmaceuticals, Inc.'s finite-lived intangible assets, accumulated amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude